|

Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening

RECRUITINGN/ASponsored by Centre Hospitalier Intercommunal Creteil
Actively Recruiting
PhaseN/A
SponsorCentre Hospitalier Intercommunal Creteil
Started2026-01-21
Est. completion2027-08
Eligibility
Age25 Years – 65 Years
Healthy vol.Accepted

Summary

In France, cervical cancer is the 12th most common female cancer with nearly 3,000 new cases per year. Since 2018, a national Organized Cervical Cancer Screening program (DOCCU) has been set up and concerns all asymptomatic women aged 25 to 65. This program, managed by the Regional Cancer Screening Coordination Centers (CRCDC), invites women who have not taken a sample within the recommended time frame to consult for screening. However, only 59% of patients participated. The intervention of the general practitioner, an essential player in prevention, could allow for better awareness. The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening.

Eligibility

Age: 25 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Woman aged 25 to 65 living in Ile-De-France
* Eligible for DOCCU (not hysterectomized, not followed for a pre-cancerous or cancerous lesion of the cervix)
* Having declared the investigating general practitioner as a treating physician (MT) and whose MT practices in the territory of a CPTS in the UPEC area
* Affiliate to a social security scheme or beneficiary of such a scheme

Exclusion Criteria:

* Patient already included in a study on DOCCU
* Patient excluded from organized screening (cervical cancer, hysterectomy).
* Patient's opposition to participating in the study

Conditions2

CancerCervical Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.